Cargando…

Emerging roles of the cellular prion protein (PrP(C)) and 37/67 kDa laminin receptor (RPSA) interaction in cancer biology

The cellular prion protein (PrP(C)) is well-known for its involvement, under its pathogenic protease-resistant form (PrP(Sc)), in a group of neurodegenerative diseases, known as prion diseases. PrP(C) is expressed in nervous system, as well as in other peripheral organs, and has been found overexpre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limone, Adriana, Maggisano, Valentina, Sarnataro, Daniela, Bulotta, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349719/ https://www.ncbi.nlm.nih.gov/pubmed/37452879 http://dx.doi.org/10.1007/s00018-023-04844-2

Ejemplares similares

The 37/67kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67kDa LR cell surface localization and interaction with the cellular prion protein
por: Sarnataro, Daniela, et al.
Publicado: (2016)

APP Maturation and Intracellular Localization Are Controlled by a Specific Inhibitor of 37/67 kDa Laminin-1 Receptor in Neuronal Cells
por: Bhattacharya, Antaripa, et al.
Publicado: (2020)

In Vitro Inhibition of Angiogenesis by Antibodies Directed against the 37kDa/67kDa Laminin Receptor
por: Khusal, Raksha, et al.
Publicado: (2013)

The 37kDa/67kDa Laminin Receptor acts as a receptor for Aβ(42) internalization
por: Da Costa Dias, Bianca, et al.
Publicado: (2014)

Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity
por: Naidoo, Kerrilyn, et al.
Publicado: (2015)

Inhibition of 37/67kDa Laminin-1 Receptor Restores APP Maturation and Reduces Amyloid-β in Human Skin Fibroblasts from Familial Alzheimer’s Disease
por: Bhattacharya, Antaripa, et al.
Publicado: (2020)

The first report of RPSA polymorphisms, also called 37/67 kDa LRP/LR gene, in sporadic Creutzfeldt-Jakob disease (CJD)
por: Yun, Jisuk, et al.
Publicado: (2011)

Interactions of the 67 kDa laminin receptor and its precursor with laminin
por: Fatehullah, Aliya, et al.
Publicado: (2009)

High Resolution Imaging Study of Interactions between the 37 kDa/67 kDa Laminin Receptor and APP, Beta-Secretase and Gamma-Secretase in Alzheimer's Disease
por: Jovanovic, Katarina, et al.
Publicado: (2014)

Extraribosomal functions associated with the C terminus of the 37/67 kDa laminin receptor are required for maintaining cell viability
por: Scheiman, J, et al.
Publicado: (2010)

A58 CHARACTERIZATION OF THE 37/67 KDA LAMININ RECEPTOR IN COLORECTAL CANCER CELLS
por: Cloutier, G, et al.
Publicado: (2022)

Green Tea Polyphenol EGCG Sensing Motif on the 67-kDa Laminin Receptor
por: Fujimura, Yoshinori, et al.
Publicado: (2012)

67-kDa laminin receptor and cGMP induced cancer-selective apoptosis
por: Kumazoe, Motofumi, et al.
Publicado: (2013)

MGr1-Antigen/37 kDa laminin receptor precursor promotes cellular prion protein induced multi-drug-resistance of gastric cancer
por: Luo, Guanhong, et al.
Publicado: (2017)

Expression of 32/67-kDa laminin receptor in laminin adhesion-selected human colon cancer cell lines.
por: Kim, W. H., et al.
Publicado: (1998)

Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion
por: Pesapane, Ada, et al.
Publicado: (2015)

siRNA-mediated silencing of the 37/67-kDa high affinity laminin receptor in Hep3B cells induces apoptosis
por: Susantad, Tharinee, et al.
Publicado: (2008)

Cell signaling associated with internalization of 67 kDa laminin receptor (67LR) by soluble laminin and its implication for protection against neurodegenerative diseases
por: Gopalakrishna, Rayudu, et al.
Publicado: (2019)

Differential expression and regulation of the non-integrin 37/67-kDa laminin receptor on peripheral blood leukocytes of healthy individuals and patients with rheumatoid arthritis
por: Kane, Barry A., et al.
Publicado: (2019)

67 kDa laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach?
por: Montuori, Nunzia, et al.
Publicado: (2016)

The Structure of PrP(Sc) Prions
por: Wille, Holger, et al.
Publicado: (2018)

67-kDa Laminin Receptor-Mediated Cellular Sensing System of Green Tea Polyphenol EGCG and Functional Food Pairing
por: Fujimura, Yoshinori, et al.
Publicado: (2022)

Treatment with YIGSR peptide ameliorates mouse tail lymphedema by 67 kDa laminin receptor (67LR)-dependent cell-cell adhesion
por: Sakae, Y., et al.
Publicado: (2023)

Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells
por: Satoh, K, et al.
Publicado: (1999)

Inhibition of Experimental Metastasis of Human Fibrosarcoma Cells by Anti‐recombinant 37‐kDa Laminin Binding Protein Antibody
por: Narumi, Koh, et al.
Publicado: (1999)

Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP
por: Sakudo, Akikazu, et al.
Publicado: (2015)

Exploration of the Main Sites for the Transformation of Normal Prion Protein (PrP(C)) into Pathogenic Prion Protein (PrP(sc))
por: Liu, Xi-Lin, et al.
Publicado: (2017)

Expression of high-affinity 67-kDa laminin receptors in primary breast cancers and metachronous metastatic lesions or contralateral cancers.
por: Daidone, M. G., et al.
Publicado: (1997)

Coptisine Induces Apoptosis in Human Hepatoma Cells Through Activating 67-kDa Laminin Receptor/cGMP Signaling
por: Zhou, Li, et al.
Publicado: (2018)

Heterogeneity of Abnormal Prion Protein (PrP(Sc)) in Murine Scrapie Prions Determined by PrP(Sc)-Specific Monoclonal Antibodies
por: USHIKI-KAKU, Yuko, et al.
Publicado: (2013)

Mammalian prion propagation in PrP transgenic Drosophila
por: Thackray, Alana M, et al.
Publicado: (2018)

Anti-Prion Drug mPPIg5 Inhibits PrP(C) Conversion to PrP(Sc)
por: McCarthy, James M., et al.
Publicado: (2013)

Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions
por: Miyazawa, Kohtaro, et al.
Publicado: (2015)

The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro
por: Honda, Ryo P., et al.
Publicado: (2017)

Prion protein—Semisynthetic prion protein (PrP) variants with posttranslational modifications
por: Hackl, Stefanie, et al.
Publicado: (2019)

The Functional Role of Prion Protein (PrP(C)) on Autophagy
por: Shin, Hae-Young, et al.
Publicado: (2013)

PrP(Sc) formation and clearance as determinants of prion tropism
por: Shikiya, Ronald A., et al.
Publicado: (2017)

The Multifaceted Functions of Prion Protein (PrP(C)) in Cancer
por: Abi Nahed, Roland, et al.
Publicado: (2023)

Small Protease Sensitive Oligomers of PrP(Sc) in Distinct Human Prions Determine Conversion Rate of PrP(C)
por: Kim, Chae, et al.
Publicado: (2012)

Glimepiride Reduces the Expression of PrP(C), Prevents PrP(Sc) Formation and Protects against Prion Mediated Neurotoxicity
por: Bate, Clive, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3p0gdfs30vneqkq2vnn57gm1r0